69097-642 : Emtricitabine 200 mg Oral Capsule
| NDC: | 69097-642 |
| Labeler: | Cipla USA Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Emtricitabine |
| Dosage Form: | Oral Capsule |
| Application #: | ANDA091168 |
| Rev. Date: |
Appearance:
| Markings: | EMT;200 |
| Shapes: |
Capsule |
| Colors: |
 White |
| Size (mm): | 19 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 69097-642-02: 30 CAPSULE IN 1 BOTTLE (69097‑642‑02)
- 69097-642-15: 1000 CAPSULE IN 1 BOTTLE (69097‑642‑15)
Active Ingredients:
- Emtricitabine
Dosage Strength:
- 200 mg
Inactive Ingredients:
- Mannitol
- Magnesium Stearate
- Fd&c Blue No. 1
- Titanium Dioxide
- Gelatin
- Hypromellose 2910 (15 Mpa.s)
- Sodium Lauryl Sulfate
- Ferrosoferric Oxide /
Pharmaceutical Classes:
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Nucleoside Reverse Transcriptase Inhibitors [MoA]
- Nucleosides [CS]
Related Products:
Based on records with the same trade name.- 65862-301 Emtricitabine 200 mg Oral Capsule by Aurobindo Pharma Limited
- 70518-2906 Emtricitabine 200 mg Oral Capsule by Remedyrepack Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 69097-614Next: 69097-644 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.